Physicians frequently administer diuretics to hospitalized patients in the early phase of acute renal failure (ARF), in attempts to minimize fluid overload and convert oliguric ARF to nonoliguric ARF.

MINNEAPOLIS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the ...

In a meta-analysis, researchers found no difference in all-cause mortality for intensive-care patients with fluid overload who were treated with loop diuretics, compared with those given a placebo or ...

A technology designed to prevent contrast-induced acute kidney injury demonstrated an ability to manage fluids during diuretic therapy in patients with congestive HF, according to findings presented ...

MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NUWE) Nuwellis, Inc., a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to ...

Severity of fluid overload is adversely associated with survival in critically ill children on continuous renal replacement therapy (CRRT), according to a new study. “The most significant finding was ...

Higher doses of spironolactone, a diuretic (water pill), can prevent the need for dialysis in selected heart failure patients, a UT Health San Antonio study found. The aggressive approach relieved ...

EDEN PRAIRIE, Minn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced ...

NATIONAL HARBOR, Md.—Fluid overload in adult burn patients is associated with increased mortality, data presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest. Development ...

Early findings suggest Aquadex as a potential solution to safely and effectively remove fluid volume for liver disease patients who don’t respond to diuretics MINNEAPOLIS, Feb. 06, 2024 (GLOBE ...

EDEN PRAIRIE, Minn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced ...